The development of a pseudoaneurysm is a rare complication following repair of a coarctation of the aorta. Surgical management of pseudoaneurysms is associated with high morbidity and mortality. We describe the successful endovascular deployment of a covered stent in a sick infant with a descending aorta pseudoaneurysm, following the repair of an aortic coarctation. We highlight the challenges we encountered. Endovascular repair is a safe palliative alternative to re-do open surgery in unstable infants with large pseudoaneurysms following aortic coarctation repair. The role of endovascular stents as the final definitive therapy will remain limited by the deployable, small-size stents in small, growing children.
Introduction
T he development of a pseudoaneurysm is a rare but well recognised late complication following repair of a coarctation of the aorta. Surgical management of a pseudoaneurysm post-coarctation repair is usually associated with high morbidity and mortality [1] . Currently, endovascular treatment to isolate pseudoaneurysms of the aorta is widely used in the adult population, with good outcomes [1] . However, this approach has not been widely used in children. We describe the successful endovascular deployment of a covered stent in an infant with a descending aorta pseudoaneurysm, six months after the repair of an aortic coarctation. We will highlight some of the challenges in using this approach in small infants.
Case Report
The patient was a one-year-old child with Down's syndrome. He had surgical repair for a complete atrioventricular septal defect, cooarctation of the aorta and transverse arch hypoplasia at the age of six months, at which stage he was weighing only 3.5 kg. A goretex graft was used to widen the hypoplastic arch and isthmus of the After discussion with our surgical team, surgery was felt to be risky and have a high morbidity or mortality in this small infant. A percutaneous transcatheter therapeutic approach was therefore chosen over the more invasive traditional surgical approach. Fig. 5) .
On repeat angiography (Fig. 6 ) the deployed covered stent was in good position and there was no more flow into the pseudoaneurysm. The opening of the pseudoaneurysm was occluded and the aneurysm was isolated. There was no obstruction to the left subclavian artery.
The left lung remained collapsed by the large now isolated aneurysm. Delayed surgical evacuation of the aneurysm was therefore undertaken 14 days later through a left lateral thoracotomy approach (Fig. 7) . The left lung successfully re-expanded following the surgery and the infant was discharged from hospital two weeks later. Four months after the procedure he was still doing well. However, he has been noted to develop mild systemic hypertension, highlighting that he might outgrow the 5 mm stent soon.
Discussion
Early or late development of an aortic pseudoaneurysm is a recognised but rare complication following coarctation of the aorta repair [1] . It is more common after patch aug- mentation of the aorta than after end-to-end anastomosis [1, 2] . It is often seen in patients with aortic arch hypoplasia [3, 4] . It has also been described following balloon dilatation of native coarctation of the AO [5] .
Surgical intervention has traditionally been used to manage these patients. Re-do surgery for aortic pseudoaneurysms is associated with high morbidity (paraplegia, recurrent laryngeal nerve paralysis, phrenic nerve injury) and mortality [6, 7] . Conservative management is associated with a high rate of rupture and death [8] . Endovascular treatment with stents offers a less invasive treatment approach for this group of high-risk surgical patients. This procedure has been performed in adults and older children, but has not been described in infants [1,6,8,9]. Our patient had early development of a pseudoaneurysm, occurring just six months after aortic coarctation repair. The endovascular stent approach was selected as the least risky in our patient and proved an early success. The challenges included the insertion of a large, 7F femoral artery sheath required to deploy the stent in a small infant. There is also a limit to the size of stent that can be deployed, entailing the need for future intervention as the patient outgrows the small stent. literature where this approach has been used in a young infant. The role of endovascular stents as the final definitive therapy will remain limited by the deployable, small-size stents until such a time that re-expandable or selfexpandable stents have been developed for small, growing children.
